COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 850: Articles 8491-8500  | Next

SARS-CoV-2 infections in infants in Haiti 2020-2021; evidence from a serological cohort
Louis, R., Pu, R., Logan, T., Trimmer-Smith, L., Chamblain, R., Gallagher, A., Beau De Rochars, V. M., Nelson, E. J., Cummings, D. A. T., Long, M., Morris, J. G.
10.1101/2022.03.17.22272561 — Posted: 2022-03-20
Maternal Antibody Response and Transplacental Transfer Following SARS-CoV-2 Infection or Vaccination in Pregnancy
Otero, S., Miller, E. S., Sunderraj, A., Shanes, E. D., Sakowicz, A., Goldstein, J. A., Mithal, L. B.
10.1101/2022.03.17.22272574 — Posted: 2022-03-20
A SARS-CoV-2 negative antigen rapid diagnostic in RT-qPCR positive samples correlates with a low likelihood of infectious viruses in the nasopharynx.
Correa, I. A., Faffe, D. S., Galiez, R. d. M., Goncalves, C. C. A., Maia, R., da Silva, G. P., Moreira, F. R. R., Mariani, D., Campos, M. F., Carvalho, I. L., de Souza, M. R. M., Cunha, M. S., Nascimento, E. R. d. S., Ribeiro, L. d. J., da Cruz, T. F. C., Policarpo, C., Gonzales, L., Rodgers, M. A., Berg, M., Vijesurier, R., Cloherty, G. A., HAckett, J., Ferreira Junior, O. C., Castineiras, T. M. P. P., TANURI, A., Costa, L.
10.1101/2022.03.17.22272008 — Posted: 2022-03-20
Breakthrough Covid-19 cases despite tixagevimab and cilgavimab (Evusheld™) prophylaxis in kidney transplant recipients
Benotmane, I., Velay, A., Gautier-Vargas, G., Olagne, J., Fafi-Kremer, S., Thaunat, O., Caillard, S.
10.1101/2022.03.19.22272575 — Posted: 2022-03-19
Good recovery of immunization stress-related responses presenting as cluster of stroke-like events following CoronaVac and ChAdOx1 vaccinations
Apiwattanakul, M., Suanprasert, N., Rojana-Udomsart, A., Termglinchan, T., Sinthuwong, C., Tantirittisak, T., Hanchaiphiboolkul, S., Angchaisuksiri, P., Srimahachota, S., Wongsawat, J., Stiudomkajorn, S., Kiertiburanakul, S., Techasaensiri, C., Laisuan, W., Manosuthi, W., Doungngern, P., Jaroenkunathum, W., Jivapaisarnpong, T., Panjangampatthan, A., Chimmanee, J., Chokephaibulkit, K.
10.1101/2022.03.15.22272434 — Posted: 2022-03-19
Hospital length of stay in a mixed Omicron and Delta epidemic in New South Wales, Australia
Tobin, R. J., Wood, J. G., Jayasundara, D., Sara, G., Walker, J., Martin, G., McCaw, J. M., Shearer, F. M., Price, D. J.
10.1101/2022.03.16.22271361 — Posted: 2022-03-19
COVID-19 patients have increased levels of membrane-associated and soluble CD48
Pahima, H., Zaffran, I., Ben-Chetrit, E., Jarjoui, A., Gaur, P., Manca, M. L., Reichmann, D., Orenbuch-Harroch, E., Puxeddu, I., Zinner, C., Tzankov, A., Levi-Schaffer, F.
10.1101/2022.03.18.484843 — Posted: 2022-03-19
Modelling the impact of non-pharmaceutical interventions on workplace transmission of SARS-CoV-2 in the home-delivery sector
Whitfield, C. A., Van Tongeren, M., Han, Y., Wei, H., Daniels, S. A., Regan, M., Denning, D. W., Verma, A., Pellis, L., University of Manchester COVID-19 Modelling Group, , Hall, I.
10.1101/2022.03.17.22272414 — Posted: 2022-03-18
Monoclonal antibody and antiviral therapy for treatment of mild-to-moderate COVID-19 in pediatric patients
Vora, S. B., Englund, J. A., Trehan, I., Waghmare, A., Kong, A., Adler, A., Zerr, D. M.
10.1101/2022.03.16.22272511 — Posted: 2022-03-18
Mobility was a Significant Determinant of Reported COVID-19 Incidence During the Omicron Surge in the Most Populous U.S. Counties
Harris, J. E.
10.1101/2022.03.16.22272523 — Posted: 2022-03-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).